The Role of Inflammation and Fibrosis in Interstitial Lung Disease Treatment Decisions.
Saved in:
| Title: | The Role of Inflammation and Fibrosis in Interstitial Lung Disease Treatment Decisions. |
|---|---|
| Authors: | Behr J; Department of Medicine V, LMU University Hospital, LMU Munich, Comprehensive Pneumology Center, Member of the German Center for Lung Research, Munich, Germany., Salisbury ML; Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Walsh SLF; National Heart and Lung Institute, Imperial College, London, United Kingdom., Podolanczuk AJ; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Weill Cornell Medicine, New York, New York., Hariri LP; Department of Pathology and.; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Massachusetts General Hospital, and., Hunninghake GM; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Kolb M; Firestone Institute for Respiratory Health, St. Joseph's Healthcare and McMaster University, Hamilton, Ontario, Canada., Ryerson CJ; Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Cottin V; Department of Respiratory Medicine, National Reference Centre for Rare Pulmonary Diseases, ERN-LUNG, Louis Pradel Hospital, Hospices Civils de Lyon, UMR 754, INRAE, Claude Bernard University Lyon 1, Lyon, France., Beasley MB; Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York., Corte T; Royal Prince Alfred Hospital and.; University of Sydney, Sydney, New South Wales, Australia., Glanville AR; St. Vincent's Hospital, Sydney, New South Wales, Australia., Adegunsoye A; Section of Pulmonary and Critical Care, Department of Medicine, and.; Committee on Clinical Pharmacology and Pharmacogenomics, University of Chicago, Chicago, Illinois., Hogaboam C; Women's Guild Lung Institute, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California., Wuyts WA; Unit for Interstitial Lung Diseases, Department of Respiratory Medicine, University Hospitals Leuven, Leuven, Belgium., Noth I; Division of Pulmonary and Critical Care Medicine, University of Virginia, Charlottesville, Virginia., Oldham JM; Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan., Richeldi L; Università Cattolica del Sacro Cuore, Rome, Italy.; Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Raghu G; Center for Interstitial Lung Diseases, Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, and.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington; and., Wells AU; Royal Brompton Hospital and Imperial College, London, United Kingdom. |
| Source: | American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2024 Aug 15; Vol. 210 (4), pp. 392-400. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: American Thoracic Society Country of Publication: England NLM ID: 9421642 Publication Model: Print Cited Medium: Internet ISSN: 1535-4970 (Electronic) Linking ISSN: 1073449X NLM ISO Abbreviation: Am J Respir Crit Care Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1535-4970 |
|---|---|
| DOI: | 10.1164/rccm.202401-0048PP |
